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Summary
Background:Receptors that couple to Gi and Gq often interact
synergistically in cells to elicit cytosolic Ca2+ transients that
are several-fold higher than the sum of those driven by each
receptor alone. Such synergism is commonly assumed to
be complex, requiring regulatory interaction between compo-
nents, multiple pathways, or multiple states of the target
protein.
Results: We show that cellular Gi-Gq synergism derives from
direct supra-additive stimulation of phospholipase C-b3
(PLC-b3) by G protein subunits Gbg and Gaq, the relevant
components of the Gi and Gq signaling pathways. No addi-
tional pathway or proteins are required. Synergism is quantita-
tively explained by the classical and simple two-state (inacti-
ve4active) allosteric mechanism. We show generally that
synergistic activation of a two-state enzyme reflects enhanced
conversion to the active state when both ligands are bound,
not merely the enhancement of ligand affinity predicted by
positive cooperativity. The two-state mechanism also explains
why synergism is unique to PLC-b3 among the four PLC-b iso-
forms and, in general, why one enzyme may respond synergis-
tically to two activators while another does not. Expression of
synergism demands that an enzyme display low basal activity
in the absence of ligand and becomes significant only when
basal activity is% 0.1% of maximal.
Conclusions: Synergism can be explained by a simple and
general mechanism, and such a mechanism sets parameters
for its occurrence. Any two-state enzyme is predicted to
respond synergistically to multiple activating ligands if, but
only if, its basal activity is strongly suppressed.
Introduction
Cells integrate multiple incoming signals, and a response to
one signal can depend upon the presence or intensity
of others. Most often, acute responses to multiple signals
are simply additive, either positively or negatively. Occasion-
ally, however, the response to simultaneous stimuli is mark-
edly greater than the sum of the responses to each stimulus
alone. Such superadditive responses may be quantitatively
modest, but marked synergism can essentially create a
Boolean AND gate, or coincidence detector, with which a
cell responds significantly only when two signals are present*Correspondence: ross@utsw.swmed.edusimultaneously. Superadditive responses are not frequent.
In a recent large-scale screen for signaling interactions in
macrophages, only about 1.5% of the ligand pairs that were
tested displayed significant synergism [1]. In some cases,
mechanisms of cellular synergism are well understood. These
include multiple phosphorylation events, coactivation by tran-
scription factors, induction of synthesis of subsequently regu-
lated proteins, etc. Positively cooperative binding of activating
ligands can also create apparent synergism over a narrow
range of concentrations as each ligand increases the affinity
of the other [2–4]. Scaffolding proteins and membrane
surfaces potentiate signals essentially by this mechanism
[5–7]. For many acute superadditive cellular responses,
however, mechanisms of synergism involve multiple signaling
pathways, are otherwise complex [8, 9], or are unknown.
Here we use phospholipase C-b3 (PLC-b3) to elucidate
general mechanisms for creating synergism through allosteric
regulation, and we show that PLC-b3 regulation accounts for
a well-known set of superadditive responses in diverse cells.
It has been known for about 15 years that many animal cells
and primary cell lines display synergistic Ca2+ responses to
simultaneous inputs from different G protein-coupled recep-
tors [10–19]. In these cells, synergism serves as a coincidence
detector, such that a robust Ca2+ response and downstream
physiological regulation are only observed when both G
protein pathways are activated. Such synergism is physiolog-
ically important in platelets, neurons, and macrophages [10,
13, 14, 16] and is suggested to play a role in stimulation of mito-
genesis in multiple cell types [20]. In most of these cases, one
of the two receptors activates Gq and the other activates Gi,
and synergism does not depend on which Gi- or Gq-coupled
receptor initiates the signals. Gq and Gi both activate PLC-
b isoforms, and the PLC reaction product, inositol-trisphos-
phate (IP3), triggers Ca
2+ release from the endoplasmic
reticulum to the cytosol [21]. Gq stimulates PLC-b via its Gaq
subunit, and Gi acts via its Gbg subunit [21]. Several studies
suggested that the mechanism of synergistic Ca2+ signaling
directly involves PLC activation [10, 12, 16–19, 22–24], and
recent studies in macrophages and a macrophage-like cell
line argue that synergistic stimulation of Ca2+ signaling
primarily requires the PLC-b3 isoform [10]. However, other
work suggested that cellular Gi-Gq synergism involves interac-
tion between the G proteins [25] or the IP3 receptor [26], and its
biochemical mechanism remained unknown.
We show here that purified PLC-b3 responds synergistically
to stimulation by Gaq and Gbg. Synergistic activation of PLC-
b3 can exceed ten times the sum of the responses to the indi-
vidual G protein subunits. Gbg-Gaq synergism on PLC-b3 can
thus quantitatively account for synergistic Ca2+ responses to
Gi and Gq in cells, and its biochemical behavior is qualitatively
consistent with cellular events. Additional proteins or path-
ways are not required.
We also show that the synergistic response of PLC-b3 to
Gaq and Gbg can be explained quantitatively by a simple and
classical two-state allosteric model. Synergism does not
merely reflect positively cooperative effects of each subunit
on the binding affinity of the other, but results from increased
accumulation of the active form of PLC-b3. Synergism occurs
Figure 1. Synergistic Activation of PLC-b3 by Gaq and Gbg
(A) PLC-b3 activity was assayed at 60 nM [Ca2+] with increasing concentrations of Gaq in the absence (open circles) or presence of 6 nM Gbg (closed circles).
The synergism ratio, the ratio of activities in the presence of both Gaq and Gbg to the sum of the activities in the presence of each subunit alone, is given at
each Gaq concentration.
(B) Gaq-Gbg synergism is independent of [Ca
2+]. Lower panel: PLC-b3 activity was assayed at various Ca2+ concentrations in the presence of 30 nM Gbg
(black triangles), 0.2 nM Gaq (white circles), or both 0.2 nM Gaq and 30 nM Gbg (black circles). Basal activity in the absence of G protein subunits was also
assayed, and is shown multiplied by 10 to distinguish it from baseline (open triangles). Zero Ca2+ represents 5 mM EGTA with no added Ca2+. Upper panel:
synergism ratios at each Ca2+ concentration. The ratio at zero Ca2+ is not accurate because of relative errors in assaying such low activities. The range of
activities in this experiment is greater than 2000-fold. The maximum activity shown for the combination of Gaq and Gbg (both) is about one-third that in the
presence of an optimal concentration of Gbg. Error bars show standard deviation (SD).
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trations.
The other PLC-b isoforms do not mediate synergistic Ca2+
responses in cells [10] or display synergism in vitro, even
though they are structurally homologous to PLC-b3 and
respond similarly to individual G proteins [21].
In general, why does one enzyme respond synergistically to
two activators while another does not? We show by modeling
and by analysis of PLC-b regulation that a superadditive
response by a single enzyme primarily depends on its having
very low activity in the absence of stimulating ligand. Maximal
attainable synergism by a simple two-state enzyme is approx-
imately proportional to its intrinsic bias for the inactive state.
A two-state enzyme whose intrinsic activation is R 1% of
maximal cannot display more than two-fold synergism, and it
can do so only with ligands that are fortuitously matched in
their efficacies and that are at near perfect concentrations. In
contrast, an enzyme with intrinsic activity% 0.1% will display
synergism to most activators and will do so over a broad range
of activator concentrations. Thus any allosteric enzyme with
a large dynamic range of regulation will display a synergistic
response to two or more activating ligands. Synergism, which
is widely assumed to be a complex phenomenon requiring
ligand-ligand interactions or multiple activity states, can be
described by a simple two-state allosteric equilibrium.
Results
Gaq and Gbg Stimulate PLC-b3 Superadditively
In many cells, simultaneous stimulation of receptors coupled
to Gi and Gq produces a cytosolic Ca
2+ transient that is muchlarger than the sum of the those elicited by the individual
receptors. The Ca2+ signal presumably results from Ca2+
release from endoplasmic reticulum, which is triggered by
IP3 that is produced by the activity of PLC-b. To see whether
the synergistic Ca2+ response in cells reflects direct syner-
gistic activation of PLC-b3 by Gbg and Gaq, we measured
the activity of purified PLC-b3 at increasing concentrations
of GTPgS-activated Gaq and in the presence or absence of
Gb1g2 (Figure 1A). Together, Gaq and Gbg stimulated PLC-
b3 to an activity nearly ten times the sum of the activities
elicited by the two subunits added separately. We define
‘‘synergism’’ generally by this ratio: the activity of an enzyme
or signaling pathway in the presence of two regulatory ligands
(a and b) divided by the sum of the activities elicited by each
ligand (a or b) alone (Equation 1).
Synergism = Acta;b=ðActa + ActbÞ (1)
If two activities are merely additive, the ratio will be 1.0.
Synergism is described by a ratio substantially above 1, and
ratios above 10 approach an intuitive definition of coincidence
detection.
By this definition, synergism between Gaq and Gbg occurred
over a wide range of Gaq concentrations, from 0.03 nM to 9 nM,
which approaches saturation. The extent of direct Gaq-Gbg
synergism on PLC-b3 can thus readily account for the 2- to
6-fold synergistic responses of cellular IP3-Ca
2+ pathways
that have been described for simultaneous stimulation by
Gq- and Gi-coupled receptors.
Superadditive stimulation of PLC-b3 by Gbg and Gaq also re-
sembles cellular Gi-Gq synergism qualitatively. Gbg mediates
Table 1. Gai1-GDP Blocks Gbg-Gaq Synergism
[Gaq-GTPgS] (nM) [ Gbg ] (nM) [ Gai1-GDP ] (nM) Synergism Ratio
0.2 10 0 4.6
0.2 10 30 0.59
0.2 10 30; heated 4.6
0.2 5 0 4.7
0.2 5 15 0.91
0.2 5 15; heated 4.4
Synergism ratios were determined at 0.2 nM GTPgS-activated Gaq and two
concentrations of Gbg, with or without a 3-fold molar excess of GDP-bound
Gai1. Controls contained Gai1 that had been heated at 50
C for 60 min.
Results show means from two experiments, each with triplicate determina-
tions, and are representative of two additional experiments that did not
contain the heated Gai control. Gai1-GDP also blocked stimulation by Gbg
alone (not shown).
Figure 2. A Two-State Allosteric Model for Synergistic Activation of PLC-b3
PLC can exist in one of two states, either relatively inactive (P) or highly
active (P*), with the intrinsic conformational equilibrium described by the
isomerization constant J. Gaq and Gbg can bind to either state at nonover-
lapping sites, with association constants Kq and Kb defined for the inactive
(P) conformer. Gaq and Gbg, both allosteric activators, bind relatively more
tightly to the active state, with their preference for P* over P described by the
bias constants F and G.
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to terminate signaling after GTP hydrolysis [21, 27]. Similarly,
Gai-GDP blocked both stimulation of PLC-b3 by Gbg and
its potentiationof Gaq (Table 1). Multiple Gbgdimersyield super-
additive stimulation when added with Gaq (see Table S1, avail-
able online), consistent with the occurrence of synergistic
responses in diverse cell types. Other experiments used only
Gb1g2. Gbg-Gaq synergism also requires activation of Gaq by
GTP or a nonhydrolyzable analog (GTPgS); Gaq-GDP neither
stimulates PLC-b3 nor potentiates stimulation by Gbg at the
highest concentrations tested (Table S2). Hence, all other exper-
iments shown here use Gaq that has been activated by GTPgS.
Because Gaq activated by GTPgS or GTP binds Gbg with rela-
tively low affinity [28], Gbg does not block its stimulation of
PLC-bs.
Gaq-Gbg synergism was independent of Ca
2+ concentra-
tion from well below that of resting cytosol (30 pM) to higher
than usually reported for stimulated cells (10 mM) (Figure 1B).
Responses to Gaq and Gbg should therefore be potentiative
continuously during a cytosolic Ca2+ transient. Ca2+ also had
a negligible effect on the EC50 or Hill coefficient for either G
protein subunit. Because PLC activity with either or both G
protein subunits extrapolates to zero at low Ca2+, Ca2+
appears not to alter the G protein-driven activation4deacti-
vation equilibrium but simply to act as an amplifier of
PLC activity. We therefore used 60 nM Ca2+ for all PLC-b3
experiments as a reasonable value for resting cytosolic
concentration.
Gaq-Gbg synergism is insensitive to multiple other variations
in assay conditions (mole fraction of PIP2, PLC concentration,
temperature, detergent, ionic strength, and lipid surface
composition; data not shown). Gq-Gi synergism can therefore
reasonably be expected in any cell that expresses PLC-b3.
Taken together, these data indicate that direct synergistic acti-
vation of PLC-b3 by Gaq and Gbg can account for superaddi-
tive IP3-Ca
2+ signaling in cells; no other component or pathway
is required.
General Allosteric Mechanism for Synergistic Enzyme
Activation
Because activated Gaq and Gbgboth stimulate PLC-b3 nonco-
valently, we asked whether a simple two-state allosteric model
for PLC-b3 activation can account for the markedly superaddi-
tive responses to these ligands. Such a mechanism, described
in Figure 2, demands only that (1) PLC-b3 exists in two confor-
mational states, active (P*) and inactive (P), in equilibrium
described by the constant J; (2) that both Gaq and Gbg bindreversibly and independently to PLC-b3 in either conforma-
tional state; and (3) that both G protein subunits bind more
tightly to the P* conformation, as described by the bias
constants F and G. This model is classically used to describe
allosteric activation by individual ligands [2, 3]. Note that this
two-state allosteric mechanism is quite general: it neither
requires nor suggests any particular property of the P* state
that makes it more active than P, nor any biochemical mecha-
nism for the P4P* transition. Activation may represent
substantial subunit rearrangement, minor movement of resi-
dues at or near the active site, movement of an autoinhibitory
structure, altered interaction with the membrane surface,
some other event, or a combination of such changes.
We used a combination of fitting to experimental data and
numerical simulation to ask whether the allosteric mechanism
can quantitatively account for both the individual and the
synergistic activation of PLC-b3 by Gaq and Gbg. The activity
of PLC-b3 was measured over a wide range of concentrations
of activated Gaq and Gbg, covering almost a 600-fold range of
activities (Figure 3). These data were fit to an equilibrium equa-
tion (Equation 2) that describes the model of Figure 2. It defines
PLC activity as the product of its maximal intrinsic-specific
activity, Z, and the fraction of PLC in the four active species
shown in Figure 2. The numerator sums each active species
and the denominator sums all species. Although this equation
is long, it contains few free parameters: binding constants for
Gaq and Gbg (defined for the less active state); an equilibrium
constant J that describes the inactive-active conformational
equilibrium in the absence of ligand; and two bias constants,
F and G, that describe the preference of Gaq and Gbg for
Figure 3. Coordinate Regulation of PLC-b3 by Gaq and Gbg
PLC-b3 activity was assayed at 60 nM Ca2+ over a range of concentrations of Gaq and Gbg chosen to optimize fitting the data to the scheme shown in
Figure 2. Activities are plotted against the concentration of Gaq (A) and Gbg (B) at various fixed concentrations of the other subunit. One hundred data points,
averages of duplicates, with ranges, are shown out of a total of 115. Solid lines are simulations based on the scheme in Figure 2 and the parameter values in
Table 2.
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the less active P state has zero activity, which is approximately
correct because maximal activity is more than 500-fold above
basal:Activity =
Z  J + J  F  Kq  ½Gaq+ J G  Kb  ½Gbg+ J G  Kb  ½Gbg  F  Kq  ½Gaq
J + J  F  Kq  ½Gaq+ J G  Kb  ½Gbg + J G  Kb ½Gbg  F  Kq ½Gaq+ 1 +Kq  ½Gaq +Kb  ½Gbg+Kb ½Gbg  Kq  ½Gaq
(2)The response of PLC-b3 to a matrix of concentrations of Gaq
and Gbg was well fit by the allosteric model. Values of
constants displayed tolerable statistical errors (Table 2), and
overlay of the model-based simulation on the experimental
data was clear throughout the ranges of Gaq and Gbg concen-
tration (Figures 3 and 4). Values of maximum activities, EC50,
and Hill coefficient were all approximated well (Figure 3). Qual-
itatively similar fits were obtained for two additional similar
experiments (not shown). Experimental data are thus consis-
tent with the simple two-state model. To corroborate the
values for J, F, and G, we also estimated them from activities
measured in the presence of a single high concentration of
Gaq, Gbg, or both (Table 2). This method is independent of
Kb, Kq, and Z. Values for J and G were similar to those derived
from fitting the complete matrix of activities; the value of F was
somewhat higher but does not change maximal predicted
activation by Gaq because even the lower value predicts
substantial activation.
The data of Figure 3 and Table 2 indicate that PLC-b3
resides w99.9% in the inactive state in the absence of G
protein under these assay conditions. (Fractional basal
activity = J / (1 + J).) Saturating Gaq stimulates w250-fold
and saturating Gbg stimulates about 50-fold. Combination of
saturating Gaq and Gbg together produced about 80% of
theoretical total activation (w600-fold) (Table 2). Each subunit
thus markedly potentiated PLC-b3 activation by the other.Gbg and Gaq also each decreased the EC50 of the other
(Figure S1), indicating that each G protein subunit reciprocally
increases the other’s affinity for PLC-b3. Based on the param-
eters of Table 2, each subunit increases the affinity of theother about 19-fold, representing DDG w 1.8 Kcal for the
binding interaction. Such positively cooperative binding is
also predicted by the basic allosteric model, which was devel-
oped to describe effects on ligand affinity [2, 3]. Note,
however, that synergism does not merely reflect the recip-
rocal increase in the affinity of each subunit by the other.
Synergism is above 7-fold at saturating concentrations of
Gbg and remains above 2-fold at the highest concentrations
of both subunits.
The extent and concentration dependence of Gaq-Gbg
synergism also agree well with simulation based on the allo-
steric model (Figure 4), and comparison of data and simula-
tion point out general aspects of allosteric synergism. The
synergism ratio displays a pronounced peak at intermediate
concentrations of both Gbg and Gaq, with a peak value of
10. The ratio falls off at high Gaq concentrations but is signif-
icantly greater than 2.0 even at saturating concentrations of
Gaq and Gbg and remains above 1.0 at very low concentra-
tions where activation is minimal. The Gbg concentration did
not have a marked effect on the maximally synergistic
concentration of Gaq, nor did Gaq alter the maximally syner-
gistic concentration of Gbg. In all of these aspects, the
model-based simulation quantitatively mirrored the experi-
mental data. The two-state allosteric model can thus account
for both independent and synergistic regulation of PLC-b3 at
steady-state.
Figure 4. Gaq-Gbg Synergism Is Maximal at Intermediate G Protein Concentrations
(A) The data from the experiment shown in Figure 2, PLC-b3 activities assayed over a range of concentrations of Gaq and Gbg, are replotted as synergism
ratios, calculated as described in the legend to Figure 1. Each vertex on the surface represents a ratio calculated from the three assays (PLC-b3 plus Gaq,
Gbg, or both), each performed in duplicate. This plot is similar to those derived from two other similar experiments.
(B) Synergism ratios for the experiment in Figure 4A were simulated according to the allosteric model and the parameters shown in Table 2.
Coincidence Detection by Two-State Enzymes: PLC-b3
1331Other PLC-b Isoforms Do Not Display Gaq-Gbg Synergism
Seaman and coworkers [10] reported that only the PLC-b3 iso-
form produces synergistic responses to Gi- and Gq-coupled
receptors in macrophages, even though the four PLC-b
isoforms are structurally homologous and PLC-b1, -b2, and
-b3 are all individually stimulated by both Gaq and Gbg. We
surveyed activation of PLC-b1, PLC-b2, and PLC-b4 over
a wide range of concentrations of both subunits and under
diverse assay conditions but found that stimulation by Gbg
and Gaq was always additive or less than additive for these
three isoforms (examples in Figures S2 and S3). The synergism
ratio never significantly exceeded 1.0. This negative finding is
thus consistent with the cellular behavior reported for the other
isoforms.Table 2. Allosteric Model Parameters for PLC-b3
Matrix Fit 4-Point Fit
Z 5300 6 130 min21
J 0.00150 6 0.00047 0.00094 6 0.00002
Kq 0.220 6 0.042 nM
21
F 434 6 154 1700 6 300
Kb 0.0307 6 0.0056 nM
21
G 45.9 6 9.0 41 6 1.1
Values for the parameters of the allosteric model (Figure 2) were estimated
in two ways. Matrix fit parameters (6 standard error) were obtained by fitting
data from the experiment shown in Figure 3, which was performed at 60 nM
Ca2+. The complete experiment contained additional data points that were
included to improve the quality of the fit based on the results of pilot exper-
iments. Z is the maximum specific activity of the PLC under these assay
conditions and varies among assays according to the preparation of phos-
pholipid substrate vesicles. 4-point fit parameters (average of three exper-
iments, 6 SD) were calculated from activities obtained at saturating values
of Gaq, Gbg, both, or neither. The 4-point fit is independent of Z, Kq, and Kb.
Details are in the Supplemental Information.What Determines Synergism for a Two-State, Multiactivator
Allosteric Enzyme?
If the simple model of Figure 2 quantitatively explains syner-
gistic stimulation of PLC-b3 by Gaq and Gbg, why do the
closely related PLC-b1 and PLC-b2 isoforms not give a syner-
gistic response? More generally, when will an enzyme that is
stimulated by noncovalent binding of two or more activating
ligands display a synergistic response? How is synergism
determined by the parameters of the model?
The simulations in Figure 5 show that the intrinsic isomeriza-
tion constant J determines both the maximal synergism that
can be attained by a two-state allosteric protein and the
sensitivity of synergism to the two bias constants F and G.
Decreasing J increases synergism, and maximum attainable
synergism is approximately inversely proportional to J
(Figure 5E). For an enzyme with more than 1% intrinsic activity
without ligand (J R 0.01), maximal synergism is at most 2.4-
fold (Figure 5B). Sensitivity to the values of F and G is also
very sharp, such that only perfectly matched F and G can yield
even slight synergism. J = 0.01 is thus the practical upper limit
for synergism.At J = 0.001, about that of PLC-b3, maximal synergism is
increased to 10-fold, and the dependences on F and G are
far less strict (Figure 5C). Further, synergism is at least 3-fold
for almost all reasonable F-G combinations, similar to the
behavior of PLC-b3. Thus enzymes that respond to two ligands
will display significant potentiative responses if J < 0.001. For
lower values of J, maximal synergism increases and depen-
dence on F and G broadens, such that J = 0.0001 can pro-
duce > 25-fold synergism over a wide range of F and G
(Figure 5D).
Within the limiting maximalsynergismthat is determinedby J,
superadditive responses by a given enzyme also depend on the
bias constants (Figure 5) and on the concentrations of the
ligands relative to their intrinsic affinities for the target enzyme
(Figure 4). These two parameters are linked: the dependence
of synergism on ligand concentration varies with the bias
constants F and G at any fixed value of J (Figure 4 and
Figure 5. Predicted Effect of the Spontaneous Activation Constant J on Synergistic Activation by two allosteric regulators
The activity of an enzyme that is activated by two ligands according to the two-state model (Figure 2) was simulated over a range of values of the bias
constants F and G. For reference, J w 0.001 for PLC-b3 (Table 2). The graphs show calculated synergism ratios at four values of J: 0.1, 0.01, 0.001, and
0.0001. Note the scale differences among the synergism axes in each panel; the maximal synergism ratio for J = 0.1 is less than 1.0. The graph at the bottom
shows the nearly inverse relationship between the maximal synergism ratio and J, with a straight line of best fit drawn for reference. For the simulations, the
concentrations of the two activators were set equal to 1/Kq and 1/Kb. Changing the concentrations alters the location of the maximum synergism ratio in the
F-G plane but has no effect on its value over a wide range of concentrations (see Figures S4 and S5).
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displays a sharp dependence on ligand concentrations. When
both F and G are decreased, synergism is displayed over
a broad concentration range. Thus, for a given enzyme with
a suitable value of J, synergism is more likely for two ligands
that stimulate with bias constants on the order of 1/J. Further,when the bias constant for only one ligand is high, its optimum
concentration is tightly defined but a wide range of concentra-
tions of the weaker activator can promote synergism.
Similarly, the synergism depends less on the precise values
of F and G if the concentrations of the two activating ligands
are both low (Figure S5). Lower concentrations allow
Coincidence Detection by Two-State Enzymes: PLC-b3
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concentrations of both ligands will produce superadditive
responses only for a limited range of F and G values. This is
the situation for PLC-b3 (Figure 4). In all cases, however, J is
the primary determinant of whether synergism will be
observed, its maximal extent, and the range of ligand concen-
trations over which it occurs.
Why PLC-b1, -b2, and -b4 Do Not Respond Synergistically
to Gaq and Gbg
The two-state allosteric model also allows us to explain why
only PLC-b3 of the four PLC-b isoforms responds synergisti-
cally to inputs from Gi and Gq. PLC-b2 responds well to both
Gbg and Gaq. Its behavior was well fit by Equation 2
(Figure S3), consistent with the two-state model, but the values
for the constants were strikingly different than those for PLC-
b3 (Table S3). Most important, the value of J was 0.15, which
precludes synergism (Figure 5E). The basal activity of PLC-
b2 is 1406 45 min21 under our assay conditions (six duplicate
assays), almost 20 times that of PLC-b3. Thus, PLC-b2 fails to
display synergism because its basal activity is too high,
placing a lid on any possible synergism. In the case of PLC-
b1, basal activity is low enough to permit synergism, with J
% 0.003, but PLC-b1 is not sufficiently sensitive to activation
by Gbg. PLC-b1 is stimulated less than 4-fold by Gbg over
a wide range of Ca2+ concentrations, and it is known to be
less sensitive to Gbg than are the -b2 and -b3 isoforms [21].
For G % 4, simulations do not predict any synergism regard-
less of Gbg and Gaq concentrations, even for J w 0.001
(Figure 5, Figure S5). We saw no response of PLC-b4 to Gbg,
as reported previously [29]. Therefore, G < 2 for PLC-b4, simi-
larly disallowing Gaq-Gbg synergism. The unique ability of
PLC-b3 to respond synergistically to Gaq and Gbg, even
though the other PLC-b isoforms do not, is thus explained by
the two-state model and the values of the isomerization and
bias constants for each enzyme.
Discussion
Synergistic responses to multiple stimuli are relatively rare in
biology, but they are important because they allow cells to
respond distinctively to two simultaneous signals with novel
behaviors. Depending on the dynamics of the signaling
pathway, these novel behaviors can take several forms. If
each input elicits a minimal response alone and only simulta-
neous stimulation generates an intracellular signal, then syner-
gism creates a coincidence detector, or logical ‘‘AND’’ gate.
Each signal is permissive for the other. Alternatively, each input
may be strong enough to initiate signaling on its own, and
synergism conveys information on context; each signal is
amplified if the other input is present. Such mutual potentiation
can be quantitative, more of the same cellular signal, but such
amplification can initiate qualitatively new outputs depending
on the response thresholds of downstream proteins.
Gi-Gq Synergism
This study shows that synergistic signaling by Gi- and Gq-
coupled receptors can be explained by the superadditive
response of PLC-b3 to stimulation by Gbg and Gaq. Gi-Gq
synergism has been recognized for over 15 years and is a phys-
iologically important coincidence detector in diverse cells [10,
13, 14, 16, 20]. In cells, Gi provides the Gbg because a relatively
high Gbg concentration is required (Figures 3 and 4) and only
the Gi family heterotrimers are expressed at high enough levelsand release their Gbg adequately [21, 30]. Gis are the primary
source of Gbg for all signaling events, apparently for this
reason [30].
The 10-fold superadditive response of PLC-b3 to Gbg and
Gaq is quantitatively more than adequate to account for
cellular Gi-Gq synergism over the range of cytosolic Ca
2+
concentrations. Only PLC-b3 among the PLC-b isoforms
displays this behavior, which agrees with the finding that
only PLC-b3 permits Gi-Gq synergism in cells [10]. PLC-b3 is
thus a sensitive cellular coincidence detector, one of few allo-
steric proteins that can act in this way. Gi-Gq synergism
requires no other cellular proteins or pathways. By expression
of this isoform, cells can switch between an additive response
to Gi and Gq inputs and a coincidence detection mode.
Synergism demands that both Gaq and Gbg bind simulta-
neously to nonoverlapping sites on PLC-b, as suggested
previously [31]. Because the relative spatial orientation of the
two binding sites is unknown [32, 33], it is unclear whether
Gaq and Gbg are in contact with each other when bound to
PLC-b3. When Gaq and Gbg bind to the RGS domain of
GRK2, the two subunits make no contact and lie on essentially
opposite sides of the central GRK2 molecule [34]. The absolute
affinity of Gbg for GTPgS-activated Gaq is low enough that it
should not significantly sequester activated Gaq at the
concentrations used here [28]. Does simultaneous binding of
Gaq and Gbg to PLC-b3 alter the conformation of either G
protein subunit? The ability of Gbg to inhibit the Gq GAP
activity of PLC-b [28, 35] might involve such contact, but
synergism between Gbg and GTPgS-activated Gaq shows
that synergism as such does not involve GAP inhibition.
General Mechanism for Synergistic Response by a Single
Enzyme
The synergistic response of PLC-b3 can be described quanti-
tatively by a simple two-state allosteric model that requires
only that PLC-b3 exist in two interconvertible states with low
and high intrinsic activities (Figure 2). It neither requires nor
predicts any particular physical property of the two states or
of the transition between them. Activation may reflect gross
domain rearrangement, movement of an autoinhibitory struc-
ture, minor motion of an active site residue, or, as suggested
for the PLCs [32], reorientation with respect to the membrane
bilayer. More broadly, a general two-state model can account
for synergism regardless of whether regulation is allosteric or
covalent. Noncovalent allosteric regulation of a protein that
is also stimulated by phosphorylation, for example, can be
described by the same conformational equilibria shown in
Figure 2. Similarly, the model is applicable to signaling
proteins that are not enzymes: transcription factors, channels,
scaffolds, etc. Although any two-state model is a simplification
of a protein’s dynamic structure, this model shows that syner-
gism can be attained without supposing distinct conforma-
tions favored by each ligand or their combination.
The two-state model predicts synergism without demanding
any direct interaction between the two ligands or any direct
effect of one ligand upon the binding of the other. In terms of
Figure 2, Gbg does not change F and Gaq does not change
G. Synergism occurs simply because the binding of both
ligands favors the active state. There is no ‘‘higher-order
coupling.’’ The two-state model was developed to deal with
cooperative ligand binding [2, 3] and obviously predicts posi-
tive cooperativity of binding of the two ligands (Figure S1).
Enhanced binding can result in physiologic synergism as one
ligand allows another to act at a lower concentration than it
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described here results from an increased population of the
active state of the enzyme rather than just increased affinity
for activating ligands.
Synergistic activation in a two-state system demands that
the enzyme strongly favor the inactive state in the absence
of ligand. J must be low, and this makes intuitive sense.
Binding of each ligand drives the enzyme to its more active
form with the free energy associated with its bias constant, F
or G. This is true regardless of J. However, a low value of J
provides a large enough dynamic range of activation that the
addition of these free energies can be expressed as a syner-
gistic response in net activity. Synergism therefore does not
require any effect of one ligand upon the other ligand’s intrinsic
bias for the active state. Each ligand contributes its own DDG
to the conformational equilibrium, but synergistic activation
does not require a ‘‘DDDG’’ for ligand-ligand interaction.
Such complex interactions surely occur for some enzymes,
glycogen phosphorylase for example [38, 39], but they
demand the explicit assumption of more and different stable
conformational states, which in general is unnecessary.
Why is synergism observed so rarely if the simplest and
most common model for allostery predicts it? Again, the
answer lies with the demand for a low value of J. Maximum
synergism and J are approximately inversely proportional
(Figure 5E). If an enzyme is even 1% active without ligands,
its capacity for a synergistic response will be slight, and it
will display no synergism at all unless the bias constants for
the activators and their concentrations are fortuitously well
matched. Most allosteric enzymes are stimulated less than
100-fold by their regulatory ligands, and far smaller stimulation
can be important for cellular regulation. Yet, these proteins will
not show detectable synergistic responses.
In contrast, decreasing intrinsic activation to 0.1% allows an
enzyme to respond with robust synergism, as is the case for
PLC-b3. Maximum synergism will exceed 8-fold and will be
observed for ligands that display a relatively broad range of
bias constants. The concentration optima for synergism will
depend on the bias constants, but high synergism will be
observed over a > 10-fold range of activator concentrations
and will be more than 2-fold for all relevant activator concen-
trations. This is the case for PLC-b3 (Figure 4). Values of
J < 0.001 further broaden both the extent of synergism and
the tolerance for divergent bias constants (Figure 5).
For the PLC-bs, this analysis explains why PLC-b3 responds
synergistically to Gaq and Gbg but PLC-b1 and PLC-b2 do not.
Although PLC-b2 responds well to both G protein subunits, its
intrinsic activity is too high, J = 0.15, and no combination of
concentrations or bias constants will allow synergism. For
PLC-b1, synergism is limited because its intrinsic response
to Gbg is too low, even though it responds to Gbg significantly
both in cells and after purification.
Using the basal activation set point to determine whether an
enzyme functions as a coincidence detector or merely as
a dual responder offers distinct evolutionary advantages.
Synergism can be acquired or lost by changing J only 10-
fold, while retaining the same fractional (‘‘-fold’’) responses
to each regulatory input. An enzyme with J = 0.01 can respond
to two ligands with almost a 100-fold dynamic range but
display essentially no synergism. Alternatively, for J = 0.001,
the protein will act as a sensitive coincidence detector in addi-
tion to providing a response to each ligand. An enzyme can
evolve between these two regimes without sacrificing under-
lying allosteric regulation. Even absolute signaling activitycan be retained with only minor changes in either catalytic
activity (kcat/Km for the active state) or level of expression. In
terms of cellular signaling, changing J in the range below
0.01 will have negligible practical effect on basal activity.
The general inverse dependence of synergism on an
enzyme’s basal level of activity suggests that any enzyme
that can be activated more than 500-fold (J < 0.002) is likely
to display synergism among its activators. Examples include
adenylyl cyclases [40], some protein kinase C isoforms [41],
and the Rac exchange factor P-Rex1 [42]. Novel synergisms
should be detectable by identifying other highly regulated
enzymes. Evaluating the behavior of these enzymes in cells
should drive discovery of new synergisms, coincidence detec-
tors, and biological AND gates.
Last, even though our data do not speak to the regulation of
synergism by additional inputs, the allosteric model argues
that synergism can be modulated best by controlling the value
of J, perhaps with an added benefit of reducing basal activity.
Modulation of J by other signaling mechanisms can thus
convert an enzyme that responds independently to stimuli
into a coincidence detector.Experimental Procedures
Detailed experimental procedures are in the Supplemental Information.
All proteins were purified essentially as described [43]. Gaq and Gbg were
finally concentrated by adsorption to Q-Sepharose and elution in 5 mg/ml 3-
[(cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) to
minimize detergent in the PLC assay. Gaq was activated with GTPgS [44],
but incubation was extended to 5 hr such that Gaq that did not bind GTPgS
would be denatured and would not bind Gbg. Gb1g2 was used throughout
except in Table SI, where other Gbg isoforms were tested.
PLC activity was measured at 37C by monitoring hydrolysis of [3H]PIP2
on the surface of large unilamellar vesicles composed of PE:PS:PIP2
(20:4:1 molar ratio), roughly similar to the inner monolayer of the plasma
membrane [43]. Activities are reported as moles of IP3 produced per min
per mole of PLC. The concentration of free Ca2+ was adjusted with an
EGTA buffer and the program Bound and Determined [45] and was 60 nM
unless indicated otherwise. Because PLC-b3 can be activated more than
104-fold by combination of Ca2+, Gbg, and Gaq (see Figure 1), assay time
(2–40 min) and PLC-b3 concentration (10–4000 pM) were adjusted for
each assay to maintain linearity of activity with enzyme concentration,
obtain accurately measurable PIP2 hydrolysis, prevent substrate depletion,
and control free concentrations of G protein subunits. CHAPS inhibits stim-
ulation of PLC-b3 with IC50 = 100 mM. CHAPS was less than 20 mM in all
assays and was equalized among all samples in each assay.Supplemental Information
Supplemental Information includes five figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online
at doi:10.1016/j.cub.2010.06.013.
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